Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed director
Quarterly results
Acq. announced

ANI PHARMACEUTICALS INC (ANIP) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 4 Gassert Chad (SVP - CORP. DEV. & STRATEGY) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Sold 20,000 shares @ $56.48, valued at $1.1M
10/02/2023 8-K Quarterly results
08/25/2023 4 Gutwerg Ori (SVP, GENERICS) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Sold 13,502 shares @ $62.39, valued at $842.4k
Sold 2,059 shares @ $62.39, valued at $128.5k
Exercised 13,502 options to buy @ $31.49, valued at $425.2k
08/25/2023 4 Marken James G. (SVP OPS & PROD DEV) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Sold 3,932 shares @ $63, valued at $247.7k
Exercised 3,750 options to buy @ $40.59, valued at $152.2k
Exercised 1,667 options to buy @ $33, valued at $55k
08/23/2023 4 Leonard Matthew J (Director) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Granted 7,583 shares @ $0
08/23/2023 3 Leonard Matthew J (Director) has filed a Form 3 on ANI PHARMACEUTICALS INC
08/23/2023 8-K Appointed a new director
Docs: "ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors"
08/18/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 SC 13D/A Meridian Venture Partners II GP, L.P. reports a 9.2% stake in ANI Pharmaceuticals, Inc.
08/16/2023 4 MERIDIAN VENTURE PARTNERS II LP (10% Owner) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Sold 200,000 shares @ $58.5, valued at $11.7M
08/16/2023 4 Shanmugam Muthusamy (HEAD OF R&D, COO-NOVITIUM OPS) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Sold 27,890 shares @ $61.15, valued at $1.7M
Sold 22,110 shares @ $61.6, valued at $1.4M
08/16/2023 144 Form 144 - Report of proposed sale of securities:
08/16/2023 4 CAREY STEPHEN P. (SVP & CFO) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Sold 17,639 shares @ $61.37, valued at $1.1M
08/15/2023 4 Pera Antonio R (Director) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Sold 3,000 shares @ $60.37, valued at $181.1k
08/15/2023 4 Lalwani Nikhil (PRESIDENT & CEO) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Sold 56,666 shares @ $57.75, valued at $3.3M
Sold 11,616 shares @ $61.13, valued at $710.1k
Exercised 11,616 options to buy @ $29, valued at $336.9k
08/15/2023 144 Form 144 - Report of proposed sale of securities:
08/15/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/11/2023 144 Form 144 - Report of proposed sale of securities:
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Quarterly results
08/03/2023 4 Gassert Chad (SVP - CORP. DEV. & STRATEGY) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Sold 20,000 shares @ $51.06, valued at $1M
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 144 Form 144 - Report of proposed sale of securities:
07/20/2023 144 Form 144 - Report of proposed sale of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 144 Form 144 - Report of proposed sale of securities:
07/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/18/2023 144 Form 144 - Report of proposed sale of securities:
07/17/2023 144 Form 144 - Report of proposed sale of securities:
07/14/2023 144 Form 144 - Report of proposed sale of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy